---
figid: PMC5845002__mbo0011837560005
figlink: /pmc/articles/PMC5845002/figure/fig5/
number: FIG 5
caption: Impact of kinase inhibition on metabolic pathways. (A) Intermediates of TCA
  and methylcitrate cycles. (B) Intermediates of lysine biosynthesis. Relative metabolite
  abundances (based on ion intensities) in the presence of equimolar concentrations
  of either the kinase inhibitor or the inactive control are indicated in heat map
  format below or adjacent to each pathway intermediate detected in the metabolomics
  analysis; the 4 blocks indicate the durations of compound treatment (0, 12, 24,
  and 48 h), and color intensities correspond to Log2-fold difference relative to
  time 0 h; P = <0.05. Genes with a Log2FC value of >0.5 or ≤0.5 in the RNA-Seq results
  are represented with an arrow next to the gene, with red arrows pointing up to signify
  increased expression and green arrows pointing down to signify decreased expression.
  Primary data are shown in  (transcriptomics) and  (metabolomics).
pmcid: PMC5845002
papertitle: Multisystem Analysis of Mycobacterium tuberculosis Reveals Kinase-Dependent
  Remodeling of the Pathogen-Environment Interface.
reftext: Xavier Carette, et al. mBio. 2018 Mar-Apr;9(2):e02333-17.
pmc_ranked_result_index: '129356'
pathway_score: 0.90711
filename: mbo0011837560005.jpg
figtitle: Impact of kinase inhibition on metabolic pathways
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5845002__mbo0011837560005.html
  '@type': Dataset
  description: Impact of kinase inhibition on metabolic pathways. (A) Intermediates
    of TCA and methylcitrate cycles. (B) Intermediates of lysine biosynthesis. Relative
    metabolite abundances (based on ion intensities) in the presence of equimolar
    concentrations of either the kinase inhibitor or the inactive control are indicated
    in heat map format below or adjacent to each pathway intermediate detected in
    the metabolomics analysis; the 4 blocks indicate the durations of compound treatment
    (0, 12, 24, and 48 h), and color intensities correspond to Log2-fold difference
    relative to time 0 h; P = <0.05. Genes with a Log2FC value of >0.5 or ≤0.5 in
    the RNA-Seq results are represented with an arrow next to the gene, with red arrows
    pointing up to signify increased expression and green arrows pointing down to
    signify decreased expression. Primary data are shown in  (transcriptomics) and
     (metabolomics).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GLCE
  - DBF4
  - PYCARD
  - TCEA1
  - NF2
  - L-aspartate
  - L-aspartyl-4-phosphate
  - L-aspartate-semialdehyde
  - (25, 45)-4-hydroxyl-2,3,4,5-tetrahydrodipicolinate
  - (S)-2,3,4,5-tetrahydrodipicolinate
  - N-succinyl-2-amino-6-ketopimelate
  - acetyl-CoA
  - propanoyl
  - oxaloacetate
  - citrate
  - (25,35)-2-methylcitrate
  - S-malate
  - cis-aconitate
  - glyoxylate
  - D-threo-isocitrate
  - cis-2-methylaconitate fumarate
  - N-succinyl-L,L-2,6-diaminopimelate
  - L-diaminopimelate
  - (2R,3S)-2-methylisocitrate
  - ketoglutarate
  - succinate
  - N-acetyl-L,L-2,6-diaminopimelate meso-diaminopimelate
  - L-lysine
genes:
- word: (glce)
  symbol: GLCE
  source: hgnc_symbol
  hgnc_symbol: GLCE
  entrez: '26035'
- word: (ask)
  symbol: ASK
  source: hgnc_alias_symbol
  hgnc_symbol: DBF4
  entrez: '10926'
- word: (asc)
  symbol: ASC
  source: hgnc_alias_symbol
  hgnc_symbol: PYCARD
  entrez: '29108'
- word: (S)-2,3,4,5-tetrahydrodipicolinate
  symbol: SII
  source: hgnc_alias_symbol
  hgnc_symbol: TCEA1
  entrez: '6917'
- word: (acn)
  symbol: ACN
  source: hgnc_alias_symbol
  hgnc_symbol: NF2
  entrez: '4771'
chemicals:
- word: L-aspartate
  source: ''
  identifier: ''
- word: L-aspartyl-4-phosphate
  source: MESH
  identifier: C080396
- word: L-aspartate-semialdehyde
  source: ''
  identifier: ''
- word: (25, 45)-4-hydroxyl-2,3,4,5-tetrahydrodipicolinate
  source: MESH
  identifier: D017665
- word: (S)-2,3,4,5-tetrahydrodipicolinate
  source: MESH
  identifier: D013455
- word: N-succinyl-2-amino-6-ketopimelate
  source: MESH
  identifier: C018821
- word: acetyl-CoA
  source: MESH
  identifier: D000105
- word: propanoyl
  source: MESH
  identifier: C417902
- word: oxaloacetate
  source: MESH
  identifier: D010071
- word: citrate
  source: MESH
  identifier: C102006
- word: (25,35)-2-methylcitrate
  source: MESH
  identifier: C031605
- word: S-malate
  source: MESH
  identifier: D008293
- word: cis-aconitate
  source: MESH
  identifier: C043607
- word: glyoxylate
  source: MESH
  identifier: D006038
- word: D-threo-isocitrate
  source: MESH
  identifier: D007523
- word: cis-2-methylaconitate fumarate
  source: MESH
  identifier: C043607
- word: N-succinyl-L,L-2,6-diaminopimelate
  source: MESH
  identifier: C110965
- word: L-diaminopimelate
  source: MESH
  identifier: C110965
- word: (2R,3S)-2-methylisocitrate
  source: MESH
  identifier: C021058
- word: ketoglutarate
  source: MESH
  identifier: C029743
- word: succinate
  source: MESH
  identifier: D013386
- word: N-acetyl-L,L-2,6-diaminopimelate meso-diaminopimelate
  source: MESH
  identifier: C110965
- word: L-lysine
  source: MESH
  identifier: C114808
diseases: []
---
